Medicilon (688202)
Overview
Shanghai Medicilon Inc., a contract research organization, provides drug discovery and development services to pharmaceutical and biotechnology companies in China and internationally. The company operates in Drug Discovery and Pharmaceutical Research, and Preclinical Research segments. It offers medicinal and analytical chemistry; process development; custom and zoom in synthesis; structural, in vitro, and computational biology; protein expression and purification; protein crystallization; and r
Employees2504
Market Cap$7.5B
Revenue$1.3B
Listed OnShanghai Stock Exchange
Ticker688202
CEODr. Chun-Lin Chen Ph.D.
HeadquartersShanghai